Intercytex
Intercytex is a biopharmaceutical company based in Cambridge, UK.
History
The company was founded in 2000 and is the leading developer of regenerative medicine products to restore skin and hair.
Products
Currently the company doesn't have a marketed product, though its pipeline includes two [...] in phase II clinical development, and one in phase I clinical development.
[...] |
Phase |
Action |
|---|---|---|
cyzact |
failed in Phase III clinical trial, abandoned |
ACTIVE repair in chronic wounds |
VAVELTA |
Phase II clinical trial |
Facial rejuvenation and skin damage repair |
ICX-TRC |
Phase II clinical trial |
Hair regeneration |
ICX-SKN |
Phase I clinical trial |
Skin graft replacement |
Latest Research Developments
In June 2008, Intercytex announced positive results of their Phase II trial for a form of cloning based Hair multiplication technique called follicular cell implantation. The treatment is being hailed as a major advance in hair restoration and is backed by a £1.9 million government grant. The treatment is predicted to be available to patients within 5 years.